T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
October 10, 2019

Design for personalized therapies: reframing “delight” as the goal

Sometimes, in the world of UX and product design, “delight” means getting out of the way. Read about general approaches...

September 19, 2019

The road ahead for #regenmed

This fall, it will be 15 years since regenerative medicine faced a crisis of funding and support in the United...

June 12, 2019

ISCT 2019: data elements in the cell therapy value chain

I just got back from speaking at the International Society for Cell Therapy annual meeting, where the topic was next-gen data management....

May 31, 2019

Cell therapy and gene therapy versus cancer: 10 numbers to watch

ASCO 2019 is here! In 2018, ASCO named CAR-T cell therapy the cancer Advance of the Year, and this year’s ASCO brings more cell...